Beth Overmoyer

1 article listing Beth Overmoyer in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) Nature Communications